NEK2 Drives Trastuzumab Resistance in Gastric Cancer Through m6A Control of FN1
New research reveals that the kinase NEK2 promotes trastuzumab resistance in gastric cancer by boosting WTAP/YTHDF1-dependent m6A modification of FN1 ...
New research reveals that the kinase NEK2 promotes trastuzumab resistance in gastric cancer by boosting WTAP/YTHDF1-dependent m6A modification of FN1 ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.